Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)

preview_player
Показать описание
Jerome Pesenti is CEO at BenevolentAI. He spoke at Data Driven NYC on October 16th, 2017, about how his company is using data to help scientists generate and validate hypotheses.

Data Driven NYC is a monthly event covering Big Data and data-driven products and startups, hosted by Matt Turck, partner at FirstMark Capital.
Рекомендации по теме
Комментарии
Автор

this is great. the lack of views, likes, and comments, shows that AI in big pharma drug dev is still burgeoning in its infancy

awkb